Bioactive peptides originating from gastrointestinal endogenous proteins in the growing pig: In vivo identification

2020 ◽  
Vol 26 ◽  
Author(s):  
Lakshmi A. Dave ◽  
Maria Hayes ◽  
Leticia Mora ◽  
Shane M. Rutherfurd ◽  
Carlos A. Montoya ◽  
...  
Keyword(s):  
Serum Albumin ◽  
Bioactive Peptides ◽  
Growing Pigs ◽  
Antioxidant Power ◽  
Porcine Serum ◽  
Growing Pig ◽  
New Findings ◽  
Endogenous Proteins

Background: Recent in silico and in vitro studies have shown that gastrointestinal endogenous proteins (GEP) are a source of bioactive peptides. To date, however, the presence of such peptides in the lumen of the digestive tract has not been demonstrated. Objective: We investigated the generation of GEP-derived bioactive peptides in the growing pig fed a protein-free diet. Methods: Stomach chyme (SC) and jejunal digesta (JD) fractions from 6 growing pigs (two sampling times) were assessed for their angiotensin-I-converting enzyme (ACE-I; EC 3.4.15.1) inhibition, and antioxidant activity using the 2,2- diphenyl-1-picrylhydrazyl (DPPH) inhibition, ferric reducing antioxidant power (FRAP) and microsomal lipid peroxidation (MLP) inhibition assays. Results: Two of the fractions prepared from JD samples inhibited ACE-I and DPPH by 81 (± 2.80)% and 94 (±0.66)%. SC fractions were found to inhibit MLP between 15-39 (±3.52-1.40)%. The study identified over 180 novel peptide sequences that were related to the determined bioactivities, including a porcine serum albumin-derived peptide (FAKTCVADE SAENCDKS), corresponding to f(7-23) of the human serum albumin peptide LVNEVTEFAKTCVADESAEN CDKSLHTLF that was previously identified from the digests of the latter GEP. Conclusions: This study provides the first in vivo evidence for GEP as a source of bioactive peptides. These new findings help advance our knowledge of the latent bioactive role of GEP-derived peptides in mammalian nutrition and health, and their potential pharmaceutical applications.

scholarly journals In Vitro-in Vivo Digestibility and Nitrogen Balance in Indigenous, Exotic and Crossbred Growing Pigs Fed Sprouted or Roasted Cowpea Diets

2021 ◽  
Author(s):  
Mfanuzile Welcome Lubisi ◽  
F Fushai ◽  
R.S Thomas ◽  
J.J. Baloyi
Keyword(s):  
Enzymatic Digestion ◽  
Growing Pigs ◽  
Feed Conversion ◽  
Large White ◽  
Period 2 ◽  
Growing Pig ◽  
Daily Body Weight ◽  
Genotype Interaction

Abstract The study evaluated effects of processing cowpeas for inclusion in maize-based diets for Windsnyer, Large-White x Landrace, and their 3-way crossbred growing pig genotypes. In-vitro, the raw and roasted cowpea diets, sprouting cowpeas decreased (P<0.05) gastric-ileal non-enzymatic (buffer-only) DM digestibility. Roasting increased (P<0.05) the colon enzymatic digestion relative to sprouting. Total ileal and colon in-vitro diet DM digestibility were not affected (P>0.05) by cowpea processing. In-vivo, Pigs consumed most (P<0.05) feed (g/day/kg BW) in period 1, with significant (P<0.05) genotype X period interaction. Both roasting and sprouting cowpeas reduced (P<0.05) dietary apparent DM digestibility. Pig daily body weight (BW) gain reduced (P<0.05) in period 3 compared to period 1. There was no (P>0.05) treatment effect on feed conversion efficiency. The 3-way crossbred pigs excreted more (P<0.05) urine N (g/dayBW0.75). Urine N excretion (g/dayBW0.75) peaked (P<0.05) in period 2 (P<0.05), with less (P<0.05) N intake (g/dayBW0.75), faecal N excretion (g/dayBW0.75) and N balance (g/dayBW0.75) than in period 3. Significant diet X genotype interaction in faecal N excretion (g/dayBW0.75) resulted from markedly high (P<0.05) in contrast to low (P<0.05) excretion. Significant genotype X period interaction resulted from the numerically (P>0.05) higher urine N excretion. In conclusion, in-vitro, sprouting shifted non-enzymatic digestion to the colon, while roasting increased colon fibrolysis, without effect on overall DM digestibility. In-vivo, the period of feeding, interpreted to reflect pig maturity, the pig genotype and cowpea processing interacted to influence apparent dietary DM digestibility and N utilization, without significant effect on the conversion efficacy of the maize-cowpea diet.

scholarly journals Current Evidence on the Bioavailability of Food Bioactive Peptides

Molecules ◽  
2020 ◽  
Vol 25 (19) ◽  
pp. 4479 ◽  
Author(s):  
Lourdes Amigo ◽  
Blanca Hernández-Ledesma
Keyword(s):  
Bioactive Peptides ◽  
Active Form ◽  
Current Evidence ◽  
Food Protein ◽  
Intestinal Epithelial ◽  
Factors Affecting ◽  
New Findings ◽  
Health Promoting

Food protein-derived bioactive peptides are recognized as valuable ingredients of functional foods and/or nutraceuticals to promote health and reduce the risk of chronic diseases. However, although peptides have been demonstrated to exert multiple benefits by biochemical assays, cell culture, and animal models, the ability to translate the new findings into practical or commercial uses remains delayed. This fact is mainly due to the lack of correlation of in vitro findings with in vivo functions of peptides because of their low bioavailability. Once ingested, peptides need to resist the action of digestive enzymes during their transit through the gastrointestinal tract and cross the intestinal epithelial barrier to reach the target organs in an intact and active form to exert their health-promoting properties. Thus, for a better understanding of the in vivo physiological effects of food bioactive peptides, extensive research studies on their gastrointestinal stability and transport are needed. This review summarizes the most current evidence on those factors affecting the digestive and absorptive processes of food bioactive peptides, the recently designed models mimicking the gastrointestinal environment, as well as the novel strategies developed and currently applied to enhance the absorption and bioavailability of peptides.

scholarly journals Perilla frutescens Leaf Extract and Fractions: Polyphenol Composition, Antioxidant, Enzymes (α-Glucosidase, Acetylcholinesterase, and Tyrosinase) Inhibitory, Anticancer, and Antidiabetic Activities

Foods ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 315
Author(s):  
Zhenxing Wang ◽  
Zongcai Tu ◽  
Xing Xie ◽  
Hao Cui ◽  
Kin Weng Kong ◽  
...  
Keyword(s):  
Ethyl Acetate ◽  
Animal Experiments ◽  
Ethyl Acetate Fraction ◽  
The Body ◽  
Total Phenolic ◽  
Antioxidant Power ◽  
Glycogen Accumulation ◽  
Inhibitory Ability

This study aims to evaluate the bioactive components, in vitro bioactivities, and in vivo hypoglycemic effect of P. frutescens leaf, which is a traditional medicine-food homology plant. P. frutescens methanol crude extract and its fractions (petroleum ether, chloroform, ethyl acetate, n-butanol fractions, and aqueous phase residue) were prepared by ultrasound-enzyme assisted extraction and liquid–liquid extraction. Among the samples, the ethyl acetate fraction possessed the high total phenolic (440.48 μg GAE/mg DE) and flavonoid content (455.22 μg RE/mg DE), the best antioxidant activity (the DPPH radical, ABTS radical, and superoxide anion scavenging activity, and ferric reducing antioxidant power were 1.71, 1.14, 2.40, 1.29, and 2.4 times higher than that of control Vc, respectively), the most powerful α-glucosidase inhibitory ability with the IC50 value of 190.03 μg/mL which was 2.2-folds higher than control acarbose, the strongest proliferative inhibitory ability against MCF-7 and HepG2 cell with the IC50 values of 37.92 and 13.43 μg/mL, which were considerable with control cisplatin, as well as certain inhibition abilities on acetylcholinesterase and tyrosinase. HPLC analysis showed that the luteolin, rosmarinic acid, rutin, and catechin were the dominant components of the ethyl acetate fraction. Animal experiments further demonstrated that the ethyl acetate fraction could significantly decrease the serum glucose level, food, and water intake of streptozotocin-induced diabetic SD rats, increase the body weight, modulate their serum levels of TC, TG, HDL-C, and LDL-C, improve the histopathology and glycogen accumulation in liver and intestinal tissue. Taken together, P. frutescens leaf exhibits excellent hypoglycemic activity in vitro and in vivo, and could be exploited as a source of natural antidiabetic agent.

An in vitro approach for demonstrating the critical role of serum albumin in the detoxication of the carbamate carbaryl at in vivo toxicologically relevant concentrations

2006 ◽  
Vol 81 (2) ◽  
pp. 113-119 ◽  
Author(s):  
Miguel A. Sogorb ◽  
Carlos Álvarez-Escalante ◽  
Victoria Carrera ◽  
Eugenio Vilanova
Keyword(s):  
Serum Albumin ◽  
Critical Role

The effect of extrusion cooking of different starch sources on the in vitro and in vivo digestibility in growing pigs

2006 ◽  
Vol 131 (1-2) ◽  
pp. 67-86 ◽  
Author(s):  
Tiehu Sun ◽  
Helle Nygaard Lærke ◽  
Henry Jørgensen ◽  
Knud Erik Bach Knudsen
Keyword(s):  
Growing Pigs ◽  
Extrusion Cooking

scholarly journals Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update

2021 ◽  
Vol 22 (17) ◽  
pp. 9508
Author(s):  
Nhung Thi Phuong Nong ◽  
Jue-Liang Hsu
Keyword(s):  
Bioactive Peptides ◽  
Protein Hydrolysate ◽  
Tyrosine Phosphatase ◽  
Food Protein ◽  
Dpp Iv ◽  
Glucosidase Inhibitors ◽  
Commercial Applications ◽  
Ptp 1B

Diabetes, a glucose metabolic disorder, is considered one of the biggest challenges associated with a complex complication of health crises in the modern lifestyle. Inhibition or reduction of the dipeptidyl peptidase IV (DPP-IV), alpha-glucosidase, and protein-tyrosine phosphatase 1B (PTP-1B) enzyme activities or expressions are notably considered as the promising therapeutic strategies for the management of type 2 diabetes (T2D). Various food protein-derived antidiabetic bioactive peptides have been isolated and verified. This review provides an overview of the DPP-IV, PTP-1B, and α-glucosidase inhibitors, and updates on the methods for the discovery of DPP-IV inhibitory peptides released from food-protein hydrolysate. The finding of novel bioactive peptides involves studies about the strategy of separation fractionation, the identification of peptide sequences, and the evaluation of peptide characteristics in vitro, in silico, in situ, and in vivo. The potential of bioactive peptides suggests useful applications in the prevention and management of diabetes. Furthermore, evidence of clinical studies is necessary for the validation of these peptides’ efficiencies before commercial applications.

scholarly journals Clearance and binding of native and defucosylated lactoferrin

1983 ◽  
Vol 212 (2) ◽  
pp. 249-257 ◽  
Author(s):  
M J Imber ◽  
S V Pizzo
Keyword(s):  
Bovine Serum Albumin ◽  
Serum Albumin ◽  
Bovine Serum ◽  
Specific Binding ◽  
Gel Filtration ◽  
Peritoneal Macrophages ◽  
Mononuclear Phagocyte ◽  
Stable Complex

These studies explore the role of carbohydrate recognition systems and the direct involvement of terminal alpha 1-3-linked fucose in the clearance of lactoferrin from the murine circulation and in the specific binding of lactoferrin to receptors on murine peritoneal macrophages. As previously reported, radiolabelled lactoferrin cleared very rapidly (t1/2 less than 1 min) after intravenous injection into mice. However, competing levels of ligands specific for the hepatic galactose receptor (asialo-orosomucoid), the hepatic fucose receptor (fucosyl-bovine serum albumin), and the mononuclear-phagocyte system pathway recognizing mannose, N-acetylglucosamine and fucose (mannosyl-, N-acetylglucosaminyl- and fucosyl-bovine serum albumin) did not block radiolabelled lactoferrin clearance in vivo or binding to mouse peritoneal macrophage monolayers in vitro. Almond emulsin alpha 1-3-fucosidase was used to prepare defucosylated lactoferrin in which 88% of the alpha 1-3-linked fucose was hydrolysed. No difference in clearance or receptor binding was observed between radiolabelled native and defucosylated lactoferrin. Fucoidin, a fucose-rich algal polysaccharide, completely inhibits the clearance in vivo and macrophage binding in vitro of lactoferrin. This effect, however, is probably not the result of competition for binding to the fucose receptor, since gel-filtration studies demonstrated formation of a stable complex between lactoferrin and fucoidin. The present results indicate that the lactoferrin-clearance pathway is distinct from several pathways mediating glycoprotein clearance through recognition of terminal galactose, fucose, N-acetylglucosamine or mannose. Furthermore, alpha 1-3-linked fucose on lactoferrin is not essential for lactoferrin clearance in vivo or specific binding to macrophage receptors in vitro.

Corona protein impacts on alternating current biosusceptometry signal and circulation times of differently coated MnFe2O4 nanoparticles

Nanomedicine ◽  
2021 ◽  
Author(s):  
Andre Gonçalves Prospero ◽  
Lais Pereira Buranello ◽  
Carlos AH Fernandes ◽  
Lucilene Delazari dos Santos ◽  
Guilherme Soares ◽  
...  
Keyword(s):  
Bovine Serum Albumin ◽  
Serum Albumin ◽  
Bovine Serum ◽  
Signal Intensity ◽  
Alternating Current ◽  
Circulation Time ◽  
Mass Spectrometry Analysis ◽  
Spectrometry Analysis

Background: We evaluated the impacts of corona protein (CP) formation on the alternating current biosusceptometry (ACB) signal intensity and in vivo circulation times of three differently coated magnetic nanoparticles (MNP): bare, citrate-coated and bovine serum albumin-coated MNPs. Methods: We employed the ACB system, gel electrophoresis and mass spectrometry analysis. Results: Higher CP formation led to a greater reduction in the in vitro ACB signal intensity and circulation time. We found fewer proteins forming the CP for the bovine serum albumin-coated MNPs, which presented the highest circulation time in vivo among the MNPs studied. Conclusion: These data showed better biocompatibility, stability and magnetic signal uniformity in biological media for bovine serum albumin-coated MNPs than for citrate-coated MNPs and bare MNPs.

Comparison of hypertonic and isotonic reference electrode junctions for measuring ionized calcium in whole blood: a clinical study

1993 ◽  
Vol 39 (6) ◽  
pp. 1082-1085 ◽  
Author(s):  
P W Masters ◽  
R B Payne
Keyword(s):  
Serum Albumin ◽  
Whole Blood ◽  
Organic Anion ◽  
Reference Electrode ◽  
Ionized Calcium ◽  
Serum Chloride ◽  
Wide Range ◽  
Clinical Measurements

Abstract We measured ionized calcium concentrations in whole blood from 91 patients who had no clinical or biochemical evidence of disturbed calcium homeostasis and who had a wide range of serum albumin concentrations. We used both a standard Ciba-Corning 634 analyzer, which has a membrane-restricted saturated KCl reference electrode bridge, and a modified instrument with a 150 mmol/L NaCl bridge. After adjusting the externally standardized values from each instrument for their least-squares regressions on pH, there was a significant correlation between ionized calcium and albumin only with the standard analyzer. In contrast, only values from the modified instrument correlated with serum chloride; this was not explained by ionic strength or organic anion interferences. We conclude that there is unlikely to be any major advantage in using a membrane-restricted isotonic NaCl reference electrode for in vitro clinical measurements, although it may be of value for in vivo monitoring. The importance of measuring serum albumin when using most commercial ionized calcium analyzers is emphasized.

Sign in / Sign up

Export Citation Format

Share Document